PE/VC investors
Private Equity (PE) and Venture Capital (VC) investors are the catalysts of innovation and growth in the business world. PE firms primarily target established companies, seeking to optimize operations and unlock value through strategic investments and management expertise. They focus on long-term growth and profitability, often preparing businesses for a future sale or IPO. VC investors, by contrast, are the adventurers of finance, injecting capital into high-potential startups and early-stage companies. They embrace risk for the possibility of outsized returns, often becoming invaluable advisors. Both investor types not only bring capital but also strategic guidance, industry connections, and market insights, propelling their portfolio companies towards success.
Investors (6,250)
Investor
Description
More information
Battery Ventures LP
Battery Ventures is a global, technology-focused investment firm. Founded in 1983, the firm makes venture-capital and private-equity investments from offices in Boston, Silicon Valley, San Francisco, Israel and London. Since inception, the firm has raised over $6.9 billion[1] and is now investing its twelfth funds, Battery Ventures XII and Battery Ventures XII Side Fund, with a combined capitalization of $1.25 billion. Battery Ventures is a global, technology-focused investment firm pursuing the most prominent companies and ideas. Founded in 1983, our firm makes venture-capital and private equity investments from six offices around the world. We work hard, but humbly, and are guided by data-driven processes. We seek out extraordinary business leaders who operate the same way
Baumgartner Family Office
The Baumgartner Family Office is a multi-family office based in Switzerland. We are proud to offer various expert services to help you build, grow, maintain and protect wealth for you and your loved ones in order to pass it on to the next generation. We enjoy a truly independent, unbiased and unconflicted position, which allows us to put our clients‘ interests first. We add value with a genuine entrepreneurial spirit and a service delivery that reaches across disciplines and borders.
BAVARIA Industries Group AG
BAVARIA Industries Group AG was founded in 2003 with the aim of actively participating. This means that we are not limited to simply holding and managing investments. We are therefore looking for companies with recognizable potential for improvement.
Bay Angels
Bay Angels was founded in 1998 by Roger King. We are Bay Area angel organization whos' members include both accredited investors and members of the venture capital community. Over the years we've helped a number of early stage companies acquire funding angel funding and launch their offerings. One of our earlier success stories was OpenTable. BayAngels provides the necessary funding to help them reach the next stage of their growth. Our investors have helped infuse dozens of early stage companies with the capital necessary to accelerate their success.
Bayan Investment Company
Bayan Investment Company is a publicly owned investment manager. The firm also provides consultancy and trading services. It provides its services to individuals and companies. The firm seeks to make direct investment, private equity investments, joint ventures, and business services functions such as business valuation and in-house investment analysis. It focuses its private equity investments in the GCC region. The firm also manages separate client-focused equity portfolios and mutual funds for its clients. It invests in the public equity markets across the globe with a focus on Kuwait. The firm also invests in money markets of Kuwait. It also invests in financial and real estate portfolios, negotiated by specialized companies and agencies. Bayan Investment Company was founded in 1997 and is based in Kuwait City, Kuwait.
BayBG
We have accompanied around 3,000 companies on their path to success in the past 45 years. We are currently involved in more than 500 medium-sized companies or start-ups with 315 million euros. We are the Bavarian market leader in private equity for small and medium-sized companies.<br />
<br />
Our partners realize their future projects with equity capital:<br />
• New investments<br />
• Internationalization measures<br />
• New Products<br />
• innovation measures<br />
• Regulation of company succession (management buy-out, management buy-in)<br />
• Implementation of turnaround projects<br />
• Business start-ups<br />
• Venture capital for start-ups
Bayern Kapital
Bayern Kapital GmbH (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications and expansion of the market share.
<br />
<br />
The requesting company has to be located in Bavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems & environmental technologies.
<br />
<br />
Bayern Kapital and its funds have invested in more than 275 companies and currently manages funds to the value of EUR 500 m. The four investing funds currently managed by Bayern Kapital are: Seedfonds Bayern, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
<br />
<br />
Partner of Seedfonds Bayern is often the High-Tech Gruenderfonds, Bonn (www.htgf.de).
<br />
<br />
The co-investing funds always cooperate with an Independent private investor
<br />
<br />
A co-operating private investor (investment company, business angel) is obligatory, must not be a shareholder of the requesting company before and is investing in the project simultaneously:
<br />
<br />
Co-operating private investor has to prove his excellence in technical and management know-how
<br />
Capital investment from additional private investor must be equal to BK-investment except in special cases. For example the private investment of Business Angels only needs to be 30 % of the total investment at the earlystage-funding
<br />
Bayern Kapital-funds as co-investor act in line with the market economy operator test using the same terms and conditions as the independent private investor (pari passu)
<br />
Co-operating private investor supports technological company comprehensively for example in questions of strategy and its realisation. Investor uses his/her network contacts particularly with regard to potential customers and partners
<br />
Constant reporting to the Bayern Kapital-fund about the economic situation and project progress
BayTech Venture Capital
BayTech Venture Capital is a European Venture Capital firm with the ambition to help the best entrepreneurs build the most successful companies in their fields of expertise. They invest at an early stage in start-up companies in the sectors Technology and Life Sciences in Western Europe, especially in Germany and France. Their contribution to success in the growth phase of these companies is not limited to capital.
Bayview Asset Management
Bayview is a leading investment firm, focused mortgage credit, mortgage-backed securities, mortgage backed securities and other mortgage-re-<br />
lated assets. We are now also looking at private equity (in particular fintech, lending and real estate).Bayview is a mortgage and credit focused asset management firm active in the US as well as Europe with $14bn in AUMs. We are building our European activites and look to invest in fintech and finance (debt and equity) financial services and real estate businesses
<br />
(equity, structured equity, mezzanine, debt) in the European market
BB Pureos Bioventures
![BB Pureos Bioventures]()
STRATEGY
Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats. We strive to impact patients’ lives by advancing innovative treatments for severe diseases.
PORTFOLIO
Our companies are developing innovative therapeutics for severe diseases and contitions. We are backing great teams with development programs that make a true difference for patients.
TEAM
We are career venture capitalists, biotech founders, former pharma and biotech executives, research scientists, medical doctors, and experienced drug developers. What unites us is the passion for biotech start-ups, innovation and the quest for new and better medicines.
